ADPT vs GILD: Which Stock is Better?
Side-by-side comparison of Adaptive Biotechnologies Corp and Gilead Sciences Inc in 2026
ADPT
Adaptive Biotechnologies Corp
$17.87
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ADPT | GILD | Winner |
|---|---|---|---|
| Market Cap | $2.67B | $154.99B | GILD |
| P/E Ratio | N/A | 19.34 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 1.0% | 0.0% | ADPT |
| Gross Margin | 65.1% | 78.7% | GILD |
Analyze ADPT
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADPT or GILD a better investment?
Comparing ADPT and GILD: Adaptive Biotechnologies Corp has a market cap of $2.67B while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADPT and GILD?
ADPT (Adaptive Biotechnologies Corp) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADPT or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADPT or GILD?
ADPT has higher revenue growth at 1.0% vs 0.0% for GILD.
Which company is more profitable: ADPT or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 65.1% for ADPT.
Which is the larger company: ADPT or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $2.67B for ADPT.
Should I buy ADPT or GILD in 2026?
Both ADPT and GILD have investment merit. ADPT trades at $17.87 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADPT and GILD stock?
Key differences: Market Cap ($2.67B vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (1.0% vs 0.0%), Gross Margin (65.1% vs 78.7%).